Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis

Five days following the 3rd cycle of nivolumab, a monoclonal antibody, which acts as immune checkpoint inhibitor against the programmed cell death protein-1, for metastatic lung adenocarcinoma, a 56-year-old woman presented at the hospital critically ill. On admission, she had severe diabetic ketoac...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocrinol Diabetes Metab Case Rep
Main Authors: Tzoulis, Ploutarchos, Corbett, Richard W, Ponnampalam, Swarupini, Baker, Elly, Heaton, Daniel, Doulgeraki, Triada, Stebbing, Justin
Format: Artigo
Jezik:Inglês
Izdano: Bioscientifica Ltd 2018
Teme:
Unusual Effects of Medical Treatment
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5863245/
https://ncbi.nlm.nih.gov/pubmed/29576870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-18-0111
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki